| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ublituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma[MeSHID:D008223] Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Chronic Lymphocytic Leukemia[MeSHID:D015451] Multiple Sclerosis[MeSHID:D009103] |
10.61 | phase 3 | antibody |
| ublituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma[MeSHID:D008223] Mucosa-Associated Lymphoid Tissue Lymphoma[MeSHID:D018442] Chronic Lymphocytic Leukemia[MeSHID:D015451] Multiple Sclerosis[MeSHID:D009103] |
10.61 | phase 3 | unknown |
| click here to return to the previous page | ||||||||